Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Selective human NK3 receptor antagonists designed at Sanofi-Synthelabo

May 31, 2000

Potent histamine H3 receptor ligands developed by Schering-Plough

May 30, 2000

Pfizer's new adenosine A2A receptor agonists useful for respiratory and inflammatory diseases

May 29, 2000

SciClone receives patent for promising cystic fibrosis treatment

May 26, 2000

PulmoSphere improves drug delivery to deep lung

May 24, 2000

New PCOs claimed by Novartis for airways diseases, cardiovascular disorders, urinary incontinence

May 23, 2000

Safe and effective bronchodilators presented by Nippon Zoki

May 23, 2000

Preparation and use of pyridazines for asthma and related disorders

May 23, 2000

Combination therapies for allergic conditions under study at Schering-Plough

May 23, 2000

Bayer introduces new allergic rhinitis Rx today in Japan

May 23, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...